Ciência e Referências
Understand the physiological foundations of Digestia GLP-1.
1. What GLP-1 does
Summary: GLP-1 receptor agonists mimic a natural gut hormone that regulates insulin secretion and appetite.
In practice: They act on the brain to reduce hunger and on the stomach to slow emptying.
How the app uses this: The simulator and diary help you track these effects daily.
References
- • Drucker DJ. Mechanisms of Action and Therapeutic Application of GLP-1. Cell Metabolism, 2018.
- • EMA — Product information: Ozempic (semaglutide)
- • American Diabetes Association — Standards of Care in Diabetes (current edition)
2. Gastric emptying
Summary: By reducing stomach motility, food remains longer in the upper digestive tract.
In practice: Large portions distend the stomach for longer, being a common trigger for nausea.
How the app uses this: The visual simulator illustrates this delay for each type of meal.
References
- • Maselli DB, Camilleri M. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity. Adv Exp Med Biol, 2021.
- • EMA — Product information: Ozempic (semaglutide)
- • EMA — Current product information: Mounjaro (tirzepatide)
3. Satiety and appetite
Summary: Eating slowly allows the brain to process satiety signals before the stomach becomes too full.
In practice: Satiety perception usually arrives earlier with GLP-1.
How the app uses this: The food guide suggests portions and practices like slow chewing.
References
- • Drucker DJ. Mechanisms of Action and Therapeutic Application of GLP-1. Cell Metabolism, 2018.
4. Why nausea may happen
Summary: Acute nausea is the most common gastrointestinal symptom, often linked to delayed emptying or dosage.
In practice: High-fat meals or excessive volume increase the risk.
How the app uses this: The symptom diary helps identify specific triggers.
References
- • Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg. Diabetes, Obesity and Metabolism, 2022.
- • EMA — Product information: Ozempic (semaglutide)
- • EMA — Current product information: Mounjaro (tirzepatide)
5. Constipation and hydration
Summary: Slower intestinal transit can cause constipation. Hydration becomes essential.
In practice: Increasing fiber without increasing water can worsen constipation.
How the app uses this: The water tracker encourages daily fractionated intake.
References
- • Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg. Diabetes, Obesity and Metabolism, 2022.
- • EMA — Product information: Ozempic (semaglutide)
6. Protein and lean mass preservation
Summary: Rapid weight loss can result in muscle loss. Protein intake helps preserve lean mass.
In practice: Protein needs vary. During weight loss, adequate protein intake, especially combined with resistance training, may help preserve lean mass. The individual target should account for weight, age, kidney function and clinical conditions.
How the app uses this: The protein calculator offers a reference for conversations with the nutritionist.
References
- • Cava E, Yeat NC, Mittendorfer B. Preserving Healthy Muscle during Weight Loss. Advances in Nutrition, 2017.
7. Food tolerance and high-fat meals
Summary: Very fatty foods already empty more slowly, and this effect may be accentuated by GLP-1 — with an intensity that varies between medications and people.
In practice: Reducing fried foods and very heavy meals may lessen reflux and discomfort symptoms in some people.
How the app uses this: The guide classifies foods to help with choices.
References
- • Maselli DB, Camilleri M. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity. Adv Exp Med Biol, 2021.
- • Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg. Diabetes, Obesity and Metabolism, 2022.
8. Why individual response varies
Summary: Factors like age, microbiota, hydration, dosage, and clinical conditions make the response to GLP-1 unique.
In practice: What works for one person may not work for another.
How the app uses this: Scores are just general guides, not absolute rules.
9. Responsible use of educational tools
Summary: Apps and internet content support, but never replace individual clinical evaluation.
In practice: The treatment decision always belongs to your doctor.
How the app uses this: The app encourages you to generate the PDF report and take it to your appointment.
10. Scientific review and updates
Summary: References and leaflets for GLP-1 medications are periodically updated by regulatory agencies.
In practice: Content should be read as general support updated as much as possible.
How the app uses this: We use pending reviews to indicate areas of constant study.
Important Note: As referências devem ser revisadas periodicamente conforme bulas, diretrizes e publicações científicas atualizadas.
The app has a strictly educational purpose and organizes data based on the physiological mechanisms described above to facilitate individual tracking. The scientific content should be periodically reviewed by a qualified professional before broad commercial use.